Fukatsu, Masahiko http://orcid.org/0000-0002-7957-0000
Ikezoe, Takayuki
Funding for this research was provided by:
Asahi Kasei Pharma Corporation
Nippon Shinyaku
Astellas Pharma
AbbVie
Otsuka Pharmaceutical
Takeda Pharmaceutical Company
Novartis
Janssen Japan
Article History
Received: 1 November 2023
Revised: 1 December 2023
Accepted: 18 December 2023
First Online: 25 January 2024
Declarations
:
: TI received honoraria from Alexion Pharmaceuticals, Chugai Pharmaceutical, Nippon Shinyaku, Pfizer Japan, and Sanofi KK; received research funding from AbbVie, Asahi Kasei Pharma Corporation, Astellas Pharma, Janssen Japan, Nippon Shinyaku, Novartis, Otsuka Pharmaceutical, and Takeda Pharmaceutical Company.